Login / Register Order My Items
Contact Us
800.227.0627
Contact Us Quote Order Login / Register

Site-Specific & Re-bridging Conjugation Services

Precision-engineered conjugation for antibodies and nanobodies using cysteine re-bridging, enzymatic ligation, and glycan or click chemistries. Achieve homogeneous conjugates, controlled DAR, and LC-MS verified quality under ISO-certified systems.

ISO 9001/13485
LC-MS/HIC/SEC-MALS QC
Bench → Preclinical
Speak to a Scientist View Capabilities

Overview

Bio-Synthesis conjugation services provide advanced site-specific platform enables homogeneous antibody-drug conjugates (ADCs) and nanobody-fluorophore conjugates through bioorthogonal click and enzymatic Sortase A labeling. We combine bis-maleimide re-bridging, enzymatic ligation, glycan-directed oxime/hydrazone, and click chemistry (DBCO↔Azide, TCO↔Tetrazine) to build homogeneous conjugates for ADC prototypes, imaging probes, and nanobody-drug conjugates.

Our linker portfolio (pyridazinedione, dibromomaleimide, Sortase A, TGase, FGE) is verified by LC-MS, HIC, and SEC-MALS under ISO 9001/13485 workflows—improving stability, pharmacokinetics, and reproducibility from discovery to preclinical scale.

Learn more about our antibody conjugation expertise or payload and label conjugation capabilities.

Engineered Cys Re-bridging (DAR≈2) Enzymatic (Sortase/TGase/FGE) Glycan (Oxime/Hydrazone) Click (DBCO / TCO)
Site-specific antibody conjugation via maleimide–thiol linking: engineered antibody (–SH) to payload

Core Conjugation Capabilities

Strategy Linker / Chemistry Applications QC Focus
Engineered Cysteine (IgG / Thiomab) Maleimide, vinylsulfone, pyridazinedione, click (DBCO–Azide / TCO–Tetrazine) ADC prototypes, precise fluorophore labeling LC–MS, HIC, SEC–MALS
Disulfide Re-bridging Bis-maleimide / dibromomaleimide, thioether re-bridging Homogeneous DAR≈2, stability improvement LC–MS subunit, DAR, SEC–MALS
Glycan-Directed NaIO₄ oxidation → oxime/hydrazone (aminooxy/hydrazide) Uniform Fc labeling with minimal CDR impact ELISA/SPR, LC–MS
Enzymatic Ligation Sortase A (LPXTG), Transglutaminase (Q-tag), FGE (formylglycine) N-/C-terminal precision Intact MS, activity assays
Nanobody (VHH/sdAb) C-terminal Cys-tag, Sortase A, DBCO–Azide or TCO–Tetrazine Imaging probes, nanobody-drug/oligo conjugates LC–MS, SEC, binding retention
Technical Notes & Sample Submission
  • Amount: ≥ 1 mg antibody (≥ 1 mg/mL); ≥ 2 mg if optimizing DAR or dual payloads.
  • Buffer: PBS/HEPES pH 7.0–7.5; avoid Tris/glycine (amines) & DTT/TCEP (reducing agents).
  • Nanobody Samples: 0.3–0.8 mg at ≥ 0.5 mg/mL; handles: C-terminal Cys-tag, azide/alkyne, or LPXTG for Sortase A.
  • Linkers Supported: Bis-maleimide, pyridazinedione, DBCO/azide, TCO/tetrazine, aminooxy/hydrazide.
  • Docs: Antibody/nanobody name, isotype/scaffold, clone/lot, concentration, buffer, desired chemistry & target DAR/DoL.
  • QC Package: LC–MS (intact/subunit), HIC (DAR), SEC–MALS (aggregation), ELISA/SPR/BLI (binding).
  • Shipping: 2–8 °C (cold pack) for liquid; dry ice for frozen; avoid weekend arrivals.
  • Return Format: PBS pH 7.4 (default) or user buffer; lyophilized on request.
  • Re-bridging Tip: Mild partial reduction (TCEP ≤ 1 mM, 5–10 min) before bis-maleimide quench.
Re-bridging: DAR ≈ 2 + restore disulfide Sortase A: terminal precision TCO/Tz + DBCO/Azide: orthogonal dual labels Glycan (Oxime/Hydrazone): uniform Fc Maleimide / Pyridazinedione: thiol-selective, stable
Linker Compatibility Table

✓ Compatible  |  △ Conditional (buffer or sequence dependent)  |  ✗ Avoid

Linker / Chemistry Cys (–SH) Amine (–NH2) Glycan (–CHO) Azide / Alkyne TCO / Tetrazine Notes
Maleimide / Vinylsulfone ✓ ✗ ✗ ✗ ✗ Thiol selective; pH 6.5–7.0; quench excess linker.
Bis-maleimide / Dibromomaleimide (Re-bridging) ✓ ✗ ✗ ✗ ✗ Disulfide re-bridging (DAR≈2) after partial reduction.
NHS / Sulfo-NHS Esters ✗ ✓ ✗ ✗ ✗ Amine coupling; avoid Tris/glycine during reaction.
Oxime / Hydrazone ✗ ✗ ✓ ✗ ✗ Glycan oxidation to –CHO; mild aqueous conditions.
Click: DBCO ↔ Azide (SPAAC) △ △ △ ✓ ✗ Copper-free; orthogonal to thiols/amines.
Click: TCO ↔ Tetrazine (IEDDA) △ △ △ ✗ ✓ Ultra-fast bioorthogonal coupling; great for dual payloads.
Pyridazinedione (Thiol-selective) ✓ ✗ ✗ △ △ Stable thio-conjugates; can combine with orthogonal click.
Enzymatic (Sortase / TGase / FGE) △ △ ✗ △ △ Depends on engineered tags and acceptor handles.

FAQ

Do you support nanobodies (VHH/sdAb)?

Yes—C-terminal Cys-tags (maleimide), Sortase LPXTG, or click handles (DBCO/azide or TCO/tetrazine) are supported. We deliver site-specific, homogeneous nanobody conjugates for imaging or payload delivery.

What information speeds up a quote?

Antibody/nanobody identity, buffer & concentration, desired chemistry (re-bridging/enzymatic/glycan/click), target DAR/DoL, QC requirements, and return buffer/format.

How do I choose between re-bridging, enzymatic, or glycan routes?

Choose re-bridging for DAR≈2 and restored disulfides; choose Sortase/TGase for terminal precision; choose glycan-directed when you need uniform Fc labeling away from CDRs. Click routes enable orthogonal dual payloads.

What’s a typical QC package?

Intact/subunit LC-MS, HIC for DAR distribution, SEC-MALS for aggregation, and binding (ELISA/SPR/BLI). Optional: release testing for cleavable linkers.

Speak to a Scientist

Tell us about your biomolecule, desired label/payload, and intended use. We’ll recommend chemistry, linker design, and release testing to meet your goals.

Full Name *
Email *
Company / Institution *
Phone *
Project Type *Pick the primary route; we’ll advise if a hybrid strategy is better.
Desired ScaleWe support bench through preclinical quantities.
Preferred Linker / Notes
Payload(s)We also support dual payloads via orthogonal click.
Project Summary
Attach Spec / Sequence (optional)Include sequence or tag info (LPXTG, Q-tag, Cys-tag) if available.

By submitting, you agree to be contacted regarding your request.

Email Instead

References

  1. Bio-Synthesis Inc. Custom Antibody Conjugation Services. www.biosyn.com
  2. Hermanson GT. Bioconjugate Techniques, 3rd ed. Academic Press, 2013.
  3. Chari RVJ et al. Antibody–Drug Conjugates. Angew Chem Int Ed. 2014;53(15):3796-3827.
  4. Glen Research — Labels & Modifiers Catalog. glenresearch.com

Have a publication citing Bio-Synthesis conjugation? Contact us to be featured here.

Why Choose Bio-Synthesis

Trusted by biotech leaders worldwide for over 40+ years of delivering high quality, fast and scalable synthetic biology solutions.

Greetings Researchers,

Please be advised that any information, guidelines, writeups, and oral/video/graphic content on our website are intended solely as general guidelines.
It is the researcher's sole responsibility to conduct thorough research on the designs of the products intended for their experiments before submitting
their designs to Biosynthesis for review of production feasibility.
Thank you for your understanding.

Quick Links